-
-
-
-
-
-
-
BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $109 at Raymond James
-
-
-
-
-
-
-
BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $97 at Oppenheimer
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Neutral Rating on BioMarin Pharmaceutical Inc. (BMRN)
-
-
-
-
-
-
-
BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $82 at Bernstein SocGen Group
-
-
-
-
-
-
-
Jefferies Reiterates Buy Rating on BioMarin Pharmaceutical Inc. (BMRN): "data looks viable and is a positive sign"
-
-
-
-
-
-
-
BioMarin Pharmaceutical (BMRN) Reiterated at Overweight by Cantor Fitzgerald After Webinar
-
-
-
-
-
-
-
BioMarin (BMRN), Ascendis (ASND) Trade Lower Following Competitor Data
-
461,032 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

